Trials / Completed
CompletedNCT03890094
Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 11,158 (actual)
- Sponsor
- Guangzhou Institute of Respiratory Disease · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to determine the safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation. A retrospective analysis was conducted on all patients undergoing bronchoscopy applying sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sufentanil | Patients were applied sufentanil and midazolam intravenously and topical anesthetized. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-03-30
- Completion
- 2018-05-30
- First posted
- 2019-03-26
- Last updated
- 2019-04-02
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03890094. Inclusion in this directory is not an endorsement.